SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-19-030357
Filing Date
2019-05-17
Accepted
2019-05-17 21:29:03
Documents
1
Period of Report
2019-05-13

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 4349
  Complete submission text file 0001104659-19-030357.txt   5676
Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE ELEVENTH FLOOR NEW YORK NY 10022 646-502-2311
STEMLINE THERAPEUTICS INC (Issuer) CIK: 0001264587 (see all company filings)

IRS No.: 450522567 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 750 LEXINGTON AVENUE, 6TH FLOOR NEW YORK NY 10024
Business Address
Hoberman Kenneth (Reporting) CIK: 0001573722 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35619 | Film No.: 19837464